By
Drug Target Review2024-09-09T12:00:58
The study’s findings could contribute to future therapeutic strategies to prevent chronic kidney disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-17T09:14:00Z
2026-06-15T12:35:00Z
2026-06-15T11:00:00Z
Sponsored by Miltenyi Biotec
2026-06-15T07:00:00Z
Contributor Professor Dipak Ramji, By Drug Target Review
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2023-02-07T15:25:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud